These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1831494)

  • 1. Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988.
    Bowman LC; Hancock ML; Santana VM; Hayes FA; Kun L; Parham DM; Furman WL; Rao BN; Green AA; Crist WM
    J Clin Oncol; 1991 Sep; 9(9):1599-608. PubMed ID: 1831494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
    Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
    J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
    Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
    Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
    J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
    De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
    J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
    Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
    J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience.
    Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Sallan SE
    J Clin Oncol; 1984 Jul; 2(7):719-32. PubMed ID: 6737018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
    Cheung NV; Heller G
    J Clin Oncol; 1991 Jun; 9(6):1050-8. PubMed ID: 2033419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.
    De Bernardi B; Carli M; Casale F; Corciulo P; Cordero di Montezemolo L; De Laurentis C; Bagnulo S; Brisigotti M; Marchese N; Garaventa A
    J Clin Oncol; 1992 Dec; 10(12):1870-8. PubMed ID: 1453202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
    Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
    J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.